0000950170-24-070620.txt : 20240607 0000950170-24-070620.hdr.sgml : 20240607 20240607161003 ACCESSION NUMBER: 0000950170-24-070620 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240606 FILED AS OF DATE: 20240607 DATE AS OF CHANGE: 20240607 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: GRETHLEIN ANDREW J CENTRAL INDEX KEY: 0001270921 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-20859 FILM NUMBER: 241029451 MAIL ADDRESS: STREET 1: 651 GATEWAY BLVD STE 950 CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: GERON CORP CENTRAL INDEX KEY: 0000886744 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 752287752 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 919 EAST HILLSDALE BOULEVARD STREET 2: SUITE 250 CITY: FOSTER CITY STATE: CA ZIP: 94404 BUSINESS PHONE: 6504737700 MAIL ADDRESS: STREET 1: 919 EAST HILLSDALE BOULEVARD STREET 2: SUITE 250 CITY: FOSTER CITY STATE: CA ZIP: 94404 FORMER COMPANY: FORMER CONFORMED NAME: GERON CORPORATION DATE OF NAME CHANGE: 19960521 4 1 ownership.xml 4 X0508 4 2024-06-06 0000886744 GERON CORP GERN 0001270921 GRETHLEIN ANDREW J C/O GERON CORPORATION 919 E. HILLSDALE BLVD, SUITE 250 FOSTER CITY CA 94404 false true false false EVP, Chief Operating Officer false Employee Stock Option (right to buy) 1.72 2024-06-06 4 A false 452804 0 A 2028-11-06 Common Stock 452804 452804 D Performance-based stock option granted on November 7, 2018 and vested in full on June 6, 2024 upon approval by the US FDA for imetelstat in lower risk MDS. /s/ Scott A. Samuels for Andrew J. Grethlein 2024-06-07